Ticker

SGMO

Sangamo Therapeutics, Inc

11 catalysts on file

SGMO

Sangamo Therapeutics, Inc

Phase 2 AI-extracted

isaralgagene civaparvovec

Fabry disease

543d ago Apr 10, 2025

SEC 8-K verified 3mo ago

Countdown card →

SGMO

Sangamo Therapeutics, Inc

PDUFA AI-extracted

isaralgagene civaparvovec

Fabry disease

97d ago Jun 30, 2026

SEC 8-K verified 3mo ago

Countdown card →

SGMO

Sangamo Therapeutics, Inc

AdCom AI-extracted

isaralgagene civaparvovec

Fabry disease

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

SGMO

Sangamo Therapeutics, Inc

Approval AI-extracted

isaralgagene civaparvovec

Fabry disease

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

SGMO

Sangamo Therapeutics, Inc

PDUFA Confirmed

ST-920

Fabry disease

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

SGMO

Sangamo Therapeutics, Inc

CRL AI-extracted

ST-920

Fabry disease

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

SGMO

Sangamo Therapeutics, Inc

Phase 1 AI-extracted

ST-503

chronic neuropathic pain

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

SGMO

Sangamo Therapeutics, Inc

Phase 2 AI-extracted

ST-503

chronic neuropathic pain

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

SGMO

Sangamo Therapeutics, Inc

Phase 1 AI-extracted

ST-506

prion disease

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

SGMO

Sangamo Therapeutics, Inc

CRL AI-extracted

isaralgagene civaparvovec

Fabry disease

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

SGMO

Sangamo Therapeutics, Inc

AdCom AI-extracted

ST-503

chronic neuropathic pain

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →